Home › Employers › Novelstar Pharmaceuticals Inc
Novelstar Pharmaceuticals Inc: H-1B salaries and sponsorship
Novelstar Pharmaceuticals Inc filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $115,000.
Does Novelstar Pharmaceuticals Inc sponsor H-1B visas?
Novelstar Pharmaceuticals Inc filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on May 19, 2023. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Scientist III | 1 | $88,155 |
| Senior Manager, Quality Assurance | 1 | $115,000 |
| Group Leader, Formulation and Process Development | 1 | $125,000 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 3 | $115,000 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Group Leader, Formulation and Process Development | $125,000 Level IV | Cranbury, NJ | May 19, 2023 | Jun 12, 2023 | Certified |
| Scientist III | $88,155 Level II | Cranbury, NJ | Sep 28, 2022 | Nov 18, 2022 | Certified |
| Senior Manager, Quality Assurance | $115,000 Level IV | Cranbury, NJ | Sep 28, 2022 | Oct 17, 2022 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).